Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study
Antineoplastic Combined Chemotherapy Protocols
Genital Neoplasms, Female
Tubal ligation is a feasible option to reduce the risk of ovarian cancer in women with BRCA1 mutations who have completed childbearing.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency